Journal Of Clinical Oncology (jco) Podcast
HERA Indicates that Adjuvant Trastuzumab Confers Equal Benefit for HER2-Positive Invasive Ductal and Invasive Lobular Breast Cancers
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:10:33
- More information
Informações:
Synopsis
This Podcast reviews the results of the analysis conducted by Metzger-Filho et al. regarding the benefit of trastuzumab for patients with invasive lobular breast cancer treated on the Herceptin Adjuvant Trial (HERA) and provides perspective regarding the clinical significance of these findings.
